The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.
Findings show that fear of prosecution can drive new infections, as it puts men off knowing their status.
Adolescent treatment non-adherence remains a major challenge in sub-Saharan Africa. Addressing structural barriers to care retention, such as violence, could be key.
Research reveals that most gay and bisexual men who stop taking pre-exposure prophylaxis (PrEP) in the USA do so because it is too expensive or they see themselves as no longer having a need for it.
Nearly one-fifth (19%) of all cancers among people living with HIV could have been avoided by not smoking according to a recent study among people living with HIV in North America.
Study finds that the risk of physical intimate partner violence (IPV) is reduced by giving regular cash payments to poor girls, but HIV infection rates are not affected.
New study provides insights into the factors that influence treatment adherence in Latin America and the Caribbean. Results show that individuals from lower resource settings often achieve higher levels of adherence, contrary to predictions.
Lancet study reveals for the first time who can benefit most from immediate antiretroviral treatment – enabling prioritisation in low-resourced settings. But who is left behind?
New study finds strong links between PrEP disruptions and intimate partner violence in Kenya and Uganda. Combined interventions could be key to improving adherence and linking victims to support services.
With three in ten gay men living with HIV engaging in chemsex in the last year in the UK, understanding its association with the country’s HIV and STI epidemics is critical to put an end to new infections.